2. 您的位置
3. 首页
4. 会议论文
5. Maintenance of the therapeutic efficacy of etanercept through 48 weeks in patients with active ankyl

Maintenance of the therapeutic efficacy of etanercept through 48 weeks in patients with active ankyl

来源 :2016年第18届亚太风湿病协会联盟大会(APLAP) | 被引量 : 0次 | 上传用户：wc836952

【作 者】

：

Y.Yujin W.Cuicui 

【机 构】

：

The First Affiliated Hospital of Sun Yat-Sen University,Rheumatology,Guangzhou,China

【出 处】

：

2016年第18届亚太风湿病协会联盟大会(APLAP)

【发表日期】

：

2016年3期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Comparison of Pamidronate and Thalidomide in the Treatment of Refractory Axial Spondyloarthritis:An

会议

Secukinumab in patients with ankylosing spondylitis:Integrated safety data from two phase 3 trials

会议

Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosin

会议

Indirect comparison of etoricoxib,celecoxib and nonselective NSAIDs for ankylosing spondylitis:netwo

会议

Indirect comparison of biological agents in juvenile idiopathic arthritis:meta-analysis of randomize

会议

Indirect comparison of TNF inhibitors for ankylosing spondylitis and non-radiographic axial spondylo

会议

Assessment of clinical efficacy of TNF-α inhibitor or thalidomide combined with sulfasalazine on act

会议

The etiology analysis of spinal surgery in Ankylosing spondylitis

会议

Extracorporeal shock wave treatment of acute gouty arthritis curative effect evaluation research

会议

Radiographic response in patients with ankylosing spondylitis during 2 years of TNF-α blocking combi

会议